【レポートの概要（一部）】
1. Report Overview
1.1 The Lyophilisation for Pharmaceuticals Overview
1.2 Lyophilisation Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Lyophilisation (Freeze Drying)
2.1 Lyophilisation Market Overview
2.2 The Benefits of Lyophilisation
2.3 Freeze Drying Equipment
2.4 The Freeze Drying Process
2.5 Current Components in Freeze Drying Technology
2.5.1 Critical Parameters in the Lyophilisation Process
2.5.2 The Stages in the Lyophilisation Process
2.5.2.1 STAGE 1: Freezing
2.5.2.2 STAGE 2: Primary Drying (Sublimation)
2.5.2.3 STAGE 3: Secondary Drying (Desorption)
2.5.3 Freeze Dried Products Characteristics
2.5.3.1 Challenges Associated with Freeze Drying
2.6 Lyophilisation: An Expensive Process
2.6.1 The Biological Market: Proportion of Lyophilisation (%)
2.6.2 Main Applications of the Lyophilisation Technology
2.6.3 Lyophilisation: Market Shares (%) for Different Sectors
2.6.4 Challenges for Freeze Drying Technology
2.6.5 Scale-up Stage for Lyophilised Products
2.6.6 Main Issues at Large-Scale Production Stage for Lyophilised Products
2.6.7 Main Challenges in a Freeze Drying Plant
2.6.8 Main Issues in Production
2.6.9 Deficiencies in a Freeze Drying Process
2.7 Challenges Facing the Lyophilisation Technology Industry and Market
2.8 Lyophilisation Regulations: Current Good Manufacturing Practices (cGMP) and Quality by Design (QbD)
2.9 Lyophilisation Products and Services Market Segmentation
2.9.1 cGMP Lyophilisers
2.9.2 Laboratory Lyophilisers
2.9.3 Lyophilisation Services
3. Lyophilisation Products and Services: World Market 2015-2025
3.1 Scope of this Report
3.2 The World Lyophilisation Market, 2013-2014
3.3 Lyophilisation Products and Services Market Segmentation, 2013-2014
3.4 Leading Lyophilised Products, 2015
3.5 World Lyophilisation Technology and Services Market: Sales Forecast 2015-2025
3.6 Leading Segments for the Lyophilisation Technology and Services: Sales Forecasts 2015-2025
3.6.1 The World Lyophilisation Market: Submarkets
3.6.2 The Changing Market Shares of the Leading Lyophilisation Submarkets, 2015-2025
3.6.3 Lyophilisation Products and Services: CAGR 2013-2025 by Segment
3.7 Market Opportunities in the Lyophilisation Products and Services Market, 2015-2025
3.7.1 The cGMP Lyophilisers Sales Forecast, 2015-2025
3.7.2 The Laboratory Lyophilisers Sales Forecast, 2015-2025
3.7.3 The Lyophilisation Services Sales Forecast, 2015-2025
3.7.4 Lyophilisation: Drivers and Restraints 2015-2025
4. Leading National Lyophilisation Markets 2015-2025
4.1 Regional Breakdown of the World Lyophilisation Products and Services Market, 2013-2014
4.2 World Lyophilisation Products and Services Market: Regional Forecasts 2015-2025
4.3 The Market Shares of the World Lyophilisation Products and Services Market, 2015-2025
4.4 Global Regulations for Lyophilisation Products and Services
4.5 The US Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.5.1 US Lyophilisation Products and Services Market: Leading Companies in the US, 2015
4.5.2 The US Keeps Dominating the Lyophilisation Products and Services Market
4.5.3 Healthcare Expenditure in the US
4.5.4 US Lyophilisation Products and Services Market: Drivers and Restraints
4.6 The Lyophilisation Products and Services Market in the Five Leading European National
Markets (EU5), 2015-2025
4.6.1 The Changing Market Shares of the EU5 Lyophilisation Products and Services Market
4.6.1.1 The German Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.6.1.2 The French Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.6.1.3 The Italian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.6.1.4 The Spanish Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.6.1.5 The UK Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.7 The Japanese Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.8 The BRIC Nations Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.8.1 The BRIC Nations: Drivers and Restraints 2015-2025
4.9 The Chinese Lyophilisation Products and Services Market 2015-2025: Overview
4.9.1 Freeze-Drying Companies Based in China
4.9.2 The Chinese Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.10 The Indian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.11 The Russian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.12 The Brazilian Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.13 The Mexican, South Korean and Turkish (MKT) Lyophilisation Products and Services
Markets: the New Emerging Economies
4.13.1 The Mexican Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.13.2 The South Korean Lyophilisation Products and Services Market Sales Forecast, 2015-2025
4.13.3 The Turkish Lyophilisation Products and Services Market Sales Forecast, 2015-2025
5. Lyophilised Products by Global Leading Applications 2015-2025
5.1 Growth Opportunities for the Lyophilisation Market: Therapeutic Areas
5.2 Leading Applications 2015-2025
5.3 Leading Sector Portfolios: Revenues by Sector 2013-2014
5.4 Lyophilisation Market Forecast by Application Sector 2015-2025
5.5 Lyophilised Drugs: Market Growth 2015-2025
5.6 The Monoclonal Antibodies Market Sales Forecast, 2015-2025
5.6.1 Monoclonal Antibodies: Drives the Use of Lyophilisation Technology and Services
5.7 The Human Insulin Market Sales Forecast, 2015-2025
5.8 The Interferon Market Sales Forecast, 2015-2025
5.8.1 Interferons: Leading Lyophilised Products
5.9 Other Recombinant Hormones Market Sales Forecast, 2015-2025
5.9.1 Erythropoietins: A Market in Decline
5.9.2 Granular-Colony Stimulating Factors (G-CSF): Cost-Effective Products
5.10 The Plasma and Recombinant Coagulating Factors Market Sales Forecast, 2015-2025
5.10.1 Leading Plasma and Recombinant Coagulating Factor Products, 2015
5.11 Other Protein Therapeutics Market Sales Forecast, 2015-2025
5.11.1 Other Protein Therapeutics Products, 2015
5.12 The Biosimilars Market Sales Forecast, 2015-2025
5.12.1 Biosimilars: Leading Products, 2015
5.13 The Vaccines Market Sales Forecast, 2015-2025
5.13.1 Top 10 Leading Vaccines in the Market, 2015
5.13.2 Leading Lyophilised Vaccines, 2015
5.14 Conclusion: Leading Applications of Lyophilisation Products and Services
6. Leading Companies in the Lyophilisation Industry Market, 2015
6.1 The Lyophilisation Industry: Highly Fragmented
6.2 Leading Equipment Providers
6.2.1 Leading Equipment Providing Organisations
6.2.1.1 SP Scientific
6.2.1.1.1 SP Scientific: Overview and Global Presence
6.2.1.1.2 SP Scientific: Lyophilisation Products Portfolio
6.2.1.1.3 SP: Recent Developments
6.2.1.1.4 Recent Acquisition: Bel-Art Products
6.2.1.1.5 SP Scientific: Lyophilisation Services Portfolio
6.2.1.2 GEA Lyophil (Part of GEA Pharma Systems)
6.2.1.2.1 GEA Lyophil GmbH: Lyophilisation Products Portfolio
6.2.1.2.2 GEA Lyophil GmbH: Lyophilisation Services Portfolio
6.2.1.3 Labconco
6.2.1.3.1 Labconco Corporation: Overview and Global Presence
6.2.1.3.2 Labconco Corporation: Lyophilisation Products Portfolio
6.2.1.3.3 Labconco Corporation: Lyophilisation Service Offerings
6.2.1.4 IIShinBioBase
6.2.1.4.1 IlShinBioBase: Overview and Global Presence
6.2.1.4.2 Recent Developments
6.2.1.4.3 IIShinBioBase: Lyophilisation Products Portfolio, 2015
6.2.1.4.4 IlShinBioBase: Lyophilisation Services Portfolio, 2015
6.2.1.5 IMA Life
6.2.1.5.1 Recent Pharmaceutical Revenue and Financial Performance,
2012-2013
6.2.1.5.2 IMA Life: Lyophilisation Products, 2015
6.2.1.5.3 IMA Life: Lyophilisation Services Portfolio
6.2.1.5.4 ICE FOG Nucleation Process
6.2.1.6 Martin Christ Gefriertrocknungsanlagen GmbH
6.2.1.6.1 Continuous Freeze Drying Operating Systems
6.2.1.6.2 Martin Christ: Services, 2015
6.3 Leading Consumables Providers
6.4 Leading Contract Manufacturing Organisations (CMOs) for Lyophilisation Services
6.4.1 Boehringer Ingelheim BioXcellence
6.4.1.1 Boehringer Ingelheim BioXcellence: Overview and Global Presence
6.4.1.2 Recent Financial Performance, 2012-2013
6.4.1.3 Contract Manufacturing: Cost Cutting Initiative
6.4.1.4 Boehringer Ingelheim BioXcellence: Prodigious Track Record
6.4.1.5 Boehringer Ingelheim BioXcellence: Service Portfolio
6.4.1.6 Boehringer Ingelheim Expands Biopharmaceuticals in China
6.4.2 Pantheon
6.4.2.1 Pantheon: Lyophilisation Capabilities, 2015
6.4.2.2 Quality Standards
6.4.3 Baxter BioPharma Solutions
6.4.3.1 Baxter BioPharma Solutions: Lyophilisation Center for Excellence
6.4.3.2 Baxter BioPharma Expansion
6.4.4 Recipharm
6.4.4.1 Revenue and Recent Performance Analysis, 2013
6.4.4.2 Recipharm: Lyophilisation Capabilities
6.4.4.3 Investment in Lyophilisation
6.4.5 IDT Biologika GmbH
6.4.5.1 Sterile Dosage Filling Capabilities: Expertise in Lyophilisation
6.4.5.2 Facility Expansion
6.4.5 Vetter Pharma-Fertigung: Overview and Global Presence
6.4.5.1 Vetter Pharma-Fertigung: Service Offerings
6.4.5.2 Vetter Pharma-Fertigung: Development Pipeline
6.4.5.3 Vetter Development Services, 2015
6.4.5.4 Vetter Commercial Manufacturing
6.4.5.5 Vetter Packaging Solutions
6.4.5.6 Vetter Answers: Specialist Knowledge
6.4.5.7 Vetter Pharma-Fertigung: Lyophilisation Products
6.4.5.8 Recent Developments: Drastically Increasing Capacity Size
7. Qualitative Analysis of the Lyophilisation Products and Services Market, 2015-2025
7.1 SWOT Analysis of the Lyophilisation for Pharmaceuticals: Products and Services market
7.1.2 Strengths
7.1.2.1 Increasing Stability and Shelf life of Pharmaceuticals: Essential
Technology for Healthcare
7.1.2.2 Ease of Reconstitution
7.1.2.3 Ease of Transport
7.1.3 Weaknesses
7.1.3.1 High Set-Up Costs
7.1.3.2 Complex Technology and Process
7.1.3.3 Slow Process
7.1.3.4 High Running Costs
7.1.3.5 Unoptimised Lyophilisation Cycle Development
7.1.4 Opportunities
7.1.4.1 Growing market in Pharmaceutical Therapeutics including Injectable Solutions, Proteins, Peptides and Vaccines
7.1.4.2 High and Growing Demand for Product and Services in the Lyophilisation Field
7.1.4.3 Ageing population
7.1.5 Threats
7.1.5.1 Stringent Regulation for Manufacturing Pharmaceuticals
7.1.5.2 Competition of Alternative Methods of Drying
7.2 Drivers and Restraints for the Lyophilisation Products and Services Market
7.3 The PESTEL Analysis of the Lyophilisation: Products and Services Market
7.3.1 Political Factors
7.3.2 Economic Factors
7.3.3 Socio-Cultural Factors
7.3.4 Technological Factors
7.3.5 Environmental Factors
7.3.6 Legal Factors
7.4 Porter’s 5 Analysis of the Lyophilisation for Pharmaceuticals Market
7.4.1 Rivalry Among Competitors [High]
7.4.2 Threat of New Entrants [Low]
7.4.3 Power of Suppliers [High]
7.4.4 Power of Buyers [High]
7.4.5 Threats of Substitutes [Medium]
7.4.5.1 The Spray Drying Method
7.4.5.2 Roche’s Precipitation Method
7.4.5.3 Vertical Integration With Technology Suppliers and Buyers
8. Expert Opinions
8.1 Interview with Dr. Steven Nail, Principle Scientist, Baxter Medical Products R&D
8.1.1 Big and Small Pharma Outsource Lyophilisation
8.1.2 A Graphic Approach to Freeze-drying Optimisation
8.1.3 Lyophilisation: Recent Technology and Developments
8.1.4 Protein Based Pharmaceuticals and Lyophilisation
8.1.5 CMOs: In-house or Outsourcing Trend?
8.1.6 R&D Key Areas
8.1.7 Baxter Biopharma Solution: Freeze-Drying Capabilities
8.2 Enrico Corona, Formulation and Process Development Manager, Patheon Italia (Ferentino site)
8.2.1 Big and Small Pharma: Use CMOs to Facilitate Lyophilisation
8.2.2 Pantheon has Preclinical and Clinical Lyophilisation Capabilities
8.2.3 Lyophilisation is An Improving Process
8.2.4 Biopharmaceutical Demands For Lyophilisation Services
8.2.5 Lyophilisation Capacity is not Keeping Up with Demand
8.2.6 Major Lyophilisation Class: Recombinant Protein Drugs
8.2.7 Scaling Up the Freeze-drying Process
8.2.8 Technology and Development
8.3 Scott Goldstein, Senior Manager at Fill-finish, Ajinomoto Althea
8.3.1 Demand for Lyophilisation in Earlier Clinical Trials
8.3.2 Flexibility Required for Different Batch Sizes
8.3.3 The Challenge of Scaling Up the Lyophilisation Process
8.3.4 Big Pharma Outsource Clinical Batch Work
8.3.5 Growing Number of Drugs Are being Lyophilised
9. Conclusions
9.1 Rapid growth in the Lyophilisation Products and Services Market: 2015-2025
9.2 Lyophilisation Services is the Leading Submarket, 2013-2014
9.3 World Lyophilisation Products and Services: Regional Markets
9.4 Revenue Growth of Applications using the Lyophilisation Products and Services Market
9.5 Leading Lyophilisation Products and Services Companies
9.6 Drivers for the Lyophilisation Product and Services Market
9.7 Restraints for the Lyophilisation Product and Services Market
9.8 Concluding Remarks
【レポート販売概要】
■ タイトル：製薬向け凍結乾燥製品・サービスの世界市場■ 英文：Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies
■ 発行日：2015年1月
■ 調査会社：visiongain
■ 商品コード：VGAIN5020407
■ 調査対象地域：世界
- ベッカー型筋ジストロフィ(Becker Muscular Dystrophy)：治療薬開発パイプライン動向（2015年上半期版）Becker Muscular Dystrophy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Becker Muscular Dystrophy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Becker Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics asse …
- 世界のマイクログリッド市場動向（2012-2016）TechNavio's analysts forecast the Global Microgrid market to grow at a CAGR of 25.7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need for better power quality. The Global Microgrid market has also been witnessing increasing R&D spending by vendors. However, the high cost needed to implement microgrids could pose a challenge to the g …
- IVFサービスの世界市場：サイクルタイプ別（新鮮なIVFサイクル（非ドナー）、解凍されたIVFサイクル（非ドナー）、およびドナー卵のIVFサイクル）、エンドユーザー別（不妊治療クリニック、病院、外科センター、および臨床研究機関）The global IVF services revenue market generated $12,506 million in 2018, and is projected to reach $25,563 million by 2026, growing at a CAGR of 9.3% from 2019 to 2026. In vitro fertilization is an assisted reproductive technology, which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm outside the body, in vitro. Rise in infertility rate, increase in trend of delaye …
- Connacher Oil and Gas Limited：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Connacher Oil and Gas Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Connacher Oil and Gas Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- 世界の遺伝子検査市場動向The term ‘Genetic Testing’ refers to tests performed on DNA and RNA samples collected from patients. The so called ‘predictive tests’ give scientists and medical professionals vital clues to how an individual may develop a disease. These innovative tests can assess the risk of onset of a specific disease (genetic) based on the mutated genetic code even before the disease is symptomatic. Today, Gen …
- 減圧弁の世界市場：種類別（直動式、パイロット式）、動作圧力別（300Psig以下、301-600Psig、600Psig以上）、エンドユーザー別（石油＆ガス、発電、化学、水＆廃水、金属＆鉱業、その他）The global pressure reducing valves market size was valued at $2,501.7 million in 2018, and is projected to reach $3,617.7 million by 2026, registering a CAGR of 4.5% from 2019 to 2026. The pressure reducing valve is a device that maintains and reduces the pressure of the liquid, steam, and gas on the outlet side. It reduces the unstable pressure in the enclosure to an adjustable pressure. It is a …
- ソリッドステートドライブ（SSD）の世界市場：SLC、MLC、TLCAbout solid state drives A solid state drive is a solid state disk or an electronic disk that is used for data storage. It is made of semiconductors and uses the same input/output interface design as HDDs and stores data in solid state memory. These devices use DRAM or NAND-based flash memory to store data. The lack of moving parts reduce the risk of mechanical failures of SSDs allowing data trans …
- 世界の糖尿病腎症治療市場動向（2014-2018）About Diabetic Nephropathy Diabetic nephropathy is a disease of the kidney glomerulus, which is caused by high blood sugar. When diabetes damages kidneys, which contain millions of tiny blood vessel clusters (glomeruli) that filter waste from the blood, this results in diabetic nephropathy, which is also known as diabetic kidney disease. Severe damage can lead to kidney failure or irreversible ESR …
- 風力タービン用ギヤボックスの世界市場2016-2020About Wind Turbine Gearbox In a wind turbine, a gearbox is used to increase the rotor speed to an extent that it matches the generator speed. The gearbox connects the low-speed shafts with the high-speed shafts. The rotational speed of the generator shaft is far higher than that of the turbine blades. The gearbox in a wind turbine does not change gears; instead it maintains a single-gear ratio bet …
- 世界のマイクロファイバーレザー市場2015Global Microfiber Leather Industry Report 2015 is a professional and in-depth study on the current state of the Microfiber Leather industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Microfiber Leather market analysis is provided for the international markets including development trends, competitive …
- スチレン系ブロック共重合体（SBC）の世界市場分析：製品別（スチレンブタジエンスチレン（SBS）、スチレンイソプレンスチレン（SIS）、水素化スチレンブロックコポリマー（HSBC））、用途別（舗装および屋根、履物、ポリマー改質、接着剤およびシーラント、ワイヤーおよびケーブル）、セグメント予測The global styrenic block copolymers (SBCs) market is expected to reach USD 10.22 billion by 2024, according to a new report by Grand View Research, Inc. Increasing consumption of advanced materials in building & construction to meet structural requirements is a key factor propelling the use of polymer modified bitumen and high-performance plastics. Structural applications requiring lightweight an …
- フレキシブル中間バルクコンテナの世界市場2017-2021About FIBC FIBCs are made of woven polypropylene or polypropylene fabric, with different basis weights and strength parameters. FIBCs or bulk bags are standardized containers used in the industrial packaging of mainly dry, granular, and semi-liquid goods. These containers and bags are intended for the protected storage and to transport and handle goods in large quantities from manufacturing center …
- 農業用アジュバント（補助剤）の世界市場予測（～2021）The agricultural adjuvants market is projected to grow at a CAGR of 5.8% from 2015, to reach a projected value of USD 3.51 Billion by 2021. The market is driven by factors such as the increasing demand for agrochemicals due to the increase in pressure on global food production and changing farming practices & technologies. The agricultural adjuvants market is segmented in two types activator and u …
- 食品・飲料産業用金属缶の世界市場2017-2021About Metal Cans Metal cans are single-walled containers made of materials such as steel and aluminum that are used for the storage and distribution of goods such as food, beverages, oil, and chemicals. Technavio’s analysts forecast the global metal cans market for food and beverage industry to grow at a CAGR of 3.06% during the period 2017-2021. [Covered in this report] The report covers the pres …
- 事業提携・ライセンシング・投資・M&A動向（四半期別）：Q4 2012Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides …
